FASN and steatosis: It also decreased acetyl coenzyme A carboxylase-1 (ACC-1) and fatty acid synthase (FAS) protein expression levels, increased mRNA levels, and inhibited hepatic citrate synthase activity and lipogenesis, and improved dyslipidemia, oxidative stress, and steatosis [57,58].